发明授权
US4064241A 7[(Carboxyoxiran-3-carboxamido)phenylacetamido]cephalosporin derivatives
失效
7 {8(羧基氧环己烷-3-甲酰氨基)苯乙酰氨基{9头孢菌素衍生物
- 专利标题: 7[(Carboxyoxiran-3-carboxamido)phenylacetamido]cephalosporin derivatives
- 专利标题(中): 7 {8(羧基氧环己烷-3-甲酰氨基)苯乙酰氨基{9头孢菌素衍生物
-
申请号: US628543申请日: 1975-11-03
-
公开(公告)号: US4064241A公开(公告)日: 1977-12-20
- 发明人: Barry Clive Ross , Braham Shroot
- 申请人: Barry Clive Ross , Braham Shroot
- 申请人地址: NY New York
- 专利权人: Pfizer Inc.
- 当前专利权人: Pfizer Inc.
- 当前专利权人地址: NY New York
- 优先权: UK48116 19741107
- 主分类号: C07D303/48
- IPC分类号: C07D303/48 ; C07D501/20 ; C07D501/24 ; C07D501/36 ; A61K31/545
摘要:
A series of novel 7-(D-.alpha.-acylaminoarylacetamido)-.DELTA..sup.3 -cephem derivatives have been prepared wherein the acyl moiety contains an epoxy group immediately adjacent to the carbonyl carbon atom. These compounds are useful as antibacterial agents for the treatment of diseases caused by Gram-negative and Gram-positive bacteria. Preferred members include 7-[D-.alpha.-(cis-2-carboxyoxiran-3-carboxamido)phenylacetamido]-3-(1-methyl-1,2,3,4-tetrazol-5-ylthiomethyl)-.DELTA..sup.3 -cephem-4-carboxylic acid and 7-[D.alpha.-(cis-2-carboxyoxiran-3-carboxamido)phenylacetamido]cephalosporanic acid. Alternate methods of preparation are provided for these compounds and the principal synthetic route is described in detail.
公开/授权文献
- US06030815A Enzymatic synthesis of oligosaccharides 公开/授权日:2000-02-29
信息查询